Related Experiment Video
Updated: Jan 10, 2026

Treatment of Facial Deformities using 3D Planning and Printing of Patient-Specific Implants
Published on: May 23, 2020
Oculofacial plastic surgeons' attitudes towards sustainability in surgery
Lucy I Mudie1, Sruti Rachapudi2, Lacey E Echalier3
1Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.
Purpose:
A survey of American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS) members' opinions and attitudes towards sustainability in oculofacial plastic surgery practice was conducted. This represents the first survey on this topic that has been conducted within the subspeciality.
Methods:
An 11-point survey about sustainability practices was posted on the ASOPRS forum and sent via email to ASOPRS members who opted-in to receive surveys. Members were able to access the survey from November 2024 to January 2025, and all responses were submitted anonymously.
Results:
A total of 114 surgeons started the survey. Of the 79 surgeons completing the survey, 68 were practicing oculofacial plastic surgeons, 10 were fellows-in-training and one was retired from clinical practice. Over 90% of respondents expressed concern about climate change and 93% agreed that the amount of waste generated during oculofacial plastic surgery is excessive. Regulatory concerns, time, and cost were the most frequently cited barriers to sustainability in oculofacial plastic surgery.
Conclusions:
There is significant interest in sustainability among ASOPRS members, and the majority of survey respondents expressed concern about climate health and the contributions of our profession to climate change. ASOPRS should consider including sustainability in its mission to advance education, research, and clinical care in oculofacial surgery.
More Related Videos
10:42A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
Published on: January 28, 2020
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025